A secondary analysis of a long-term clinical trial published in the Annals of Internal Medicine indicates that bariatric surgery outperforms medical therapy, including GLP-1 drugs, for treating type 2 diabetes and obesity across diverse income levels. The research found that surgery led to superior outcomes in blood glucose control, weight loss, and diabetes remission regardless of social determinants of health. While acknowledging the rapid evolution of more potent obesity medications, the authors maintain that metabolic surgery remains an effective and underutilized durable solution.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.